G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 118 filers reported holding G1 THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $24,808,000 | +62.1% | 474,433 | +34.8% | 0.84% | +51.3% |
| Q2 2018 | $15,300,000 | -30.0% | 352,053 | -40.3% | 0.55% | -35.3% |
| Q1 2018 | $21,850,000 | +89.6% | 589,755 | +1.5% | 0.86% | +86.9% |
| Q4 2017 | $11,524,000 | -19.9% | 580,857 | +0.5% | 0.46% | -23.7% |
| Q3 2017 | $14,388,000 | +42.7% | 578,057 | 0.0% | 0.60% | +36.7% |
| Q2 2017 | $10,081,000 | – | 578,057 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 98,482 | $1,631,000 | 0.60% |
| Opus Point Partners Management, LLC | 20,844 | $346,000 | 0.47% |
| HHLR ADVISORS, LTD. | 949,431 | $15,761,000 | 0.44% |
| Rhenman & Partners Asset Management AB | 212,169 | $3,522,000 | 0.41% |
| Virtus ETF Advisers LLC | 8,654 | $144,000 | 0.31% |
| BB BIOTECH AG | 671,925 | $11,154,000 | 0.28% |
| RA Capital Management | 363,051 | $6,027,000 | 0.26% |
| BDO Wealth Advisors, LLC | 35,234 | $585,000 | 0.17% |
| Birchview Capital, LP | 15,000 | $249,000 | 0.16% |
| SECOR Capital Advisors, LP | 37,205 | $618,000 | 0.13% |